{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:24:47Z","timestamp":1790861087593,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.brainresbull.2006.10.028","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T10:30:53Z","timestamp":1164709853000},"page":"152-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Elizabeth H.","family":"Aylward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2006.10.028_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","article-title":"Basal ganglia volume and proximity to onset in preclinical Huntington's disease","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","article-title":"Rate of caudate atrophy in preclinical and symptomatic stages of Huntington's disease","volume":"15","author":"Aylward","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.48.2.394","article-title":"Longitudinal change in basal ganglia volume in patients with Huntington's disease","volume":"48","author":"Aylward","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2006.10.028_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainresbull.2003.09.005","article-title":"Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study","volume":"62","author":"Aylward","year":"2003","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2006.10.028_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S1355617798455061","article-title":"When does Huntington's disease begin?","volume":"4","author":"Campodonico","year":"1998","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib9","unstructured":"The Food and Drug Modernization Act of 1977, Title 21 Code of Federal Regulations Part 314 Subpart H Section 314.500."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional specificity of brain atrophy in Huntington's disease","volume":"154","author":"Halliday","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.20332","article-title":"Interrater agreement in the assessment of motor manifestations of Huntington's disease","volume":"20","author":"Hogarth","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"The unified Huntington's disease rating scale: reliability and consistency","volume":"11","author":"Kieburtz","year":"1996","journal-title":"Mov. Dis."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib13","series-title":"Biomarkers and Surrogate Endpoints: Clinical Research and Applications. Proceedings of NIH-FDA Conference","first-page":"13","article-title":"Biomarkers as surrogate endpoints in clinical trials for HIV\/AIDS: a model for other diseases?","author":"Mildvan","year":"2000"},{"key":"10.1016\/j.brainresbull.2006.10.028_bib14","first-page":"593","article-title":"Anticipation and instability of IT-15 (CAG) repeats in parent-offspring pairs with Huntington disease","volume":"57","author":"Ranen","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/2.10.1547","article-title":"Correlation between the onset of Huntington's disease and length of the trinucleotide repeat in IT-15","volume":"2","author":"Stine","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.10.028_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006003248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006003248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:58:38Z","timestamp":1759780718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923006003248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":16,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0361923006003248"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.10.028","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}